Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

34 trials with published results (15%)

Research Maturity

147 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.8%

9 terminated out of 234 trials

Success Rate

94.2%

+7.7% vs benchmark

Late-Stage Pipeline

34%

80 trials in Phase 3/4

Results Transparency

23%

34 of 147 completed with results

Key Signals

34 with results94% success

Data Visualizations

Phase Distribution

196Total
Not Applicable (91)
P 1 (10)
P 2 (15)
P 3 (42)
P 4 (38)

Trial Status

Completed147
Unknown38
Recruiting16
Not Yet Recruiting11
Terminated9
Withdrawn8

Trial Success Rate

94.2%

Benchmark: 86.6%

Based on 147 completed trials

Clinical Trials (234)

Showing 20 of 20 trials
NCT07753031Not Yet RecruitingPrimary

Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease

NCT07366502Not ApplicableRecruitingPrimary

Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy

NCT06550362Phase 4Not Yet RecruitingPrimary

Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA

NCT07657455Not ApplicableNot Yet RecruitingPrimary

Daily Versus Alternate-Day Oral Iron Therapy for Anemia in Second-Trimester Pregnancy

NCT07267975Phase 3CompletedPrimary

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

NCT07633262Not ApplicableRecruitingPrimary

FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities

NCT06012760Not ApplicableRecruiting

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

NCT05340465Phase 2Recruiting

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

NCT07605676Phase 4RecruitingPrimary

Acupoint TENS vs Resistance Training for Iron Deficiency Anemia

NCT04913649Phase 4RecruitingPrimary

Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery Patients

NCT06104800Not ApplicableCompleted

Effect of Weight Loss on Hepcidin Levels and Iron Status in Subjects With Obesity.

NCT03893045Phase 3RecruitingPrimary

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

NCT07483645Active Not RecruitingPrimary

Effectiveness and Acceptability of LISEFEX® (Liposomal Iron With Vitamin C and Fiber) in People With Iron Deficiency Anemia.

NCT07397572RecruitingPrimary

Iron Supplementation and Anemia After Sleeve Gastrectomy

NCT07391371Phase 4Not Yet RecruitingPrimary

Alternate-day Versus Daily Oral Iron Therapy in Children With Iron Deficiency Anaemia

NCT03817957Phase 3CompletedPrimary

Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency

NCT06238895Phase 4Completed

Optimizing Dosing Strategies in Oral Iron Supplementation

NCT05919472Not ApplicableCompletedPrimary

Effects of Oral Iron Supplementation on Vaccine Response in Iron Deficient Kenyan Women

NCT07287371Phase 4Not Yet Recruiting

Sucrosomial Vs Intravenous Iron for Preoperative Anemia

NCT03944733Not ApplicableWithdrawnPrimary

Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions

Scroll to load more

Research Network

Activity Timeline